Literature DB >> 27723088

Automated Measurement of Blood Vessels in Tissues from Microscopy Images.

Neil J Kelly1, Nadine Dandachi1, Dmitry A Goncharov1,2, Andressa Z Pena1,2, Josiah E Radder1, Alyssa D Gregory1, Yen-Chun Lai1,2, Adriana S Leme1, Mark T Gladwin1,2, Elena A Goncharova1,2, Claudette M St Croix3, Steven D Shapiro1.   

Abstract

The quantification of tunica media thickness in histological cross sections is a ubiquitous exercise in cardiopulmonary research, yet the methods for quantifying medial wall thickness have never been rigorously examined with modern image analysis tools. As a result, inaccurate and cumbersome manual measurements of discrete wall regions along the vessel periphery have become common practice for wall thickness quantification. The aim of this study is to introduce, validate, and facilitate the use of an improved method for medial wall thickness quantification. We describe a novel method of wall thickness calculation based on image skeletonization and compare its results to those of common techniques. Using both theoretical and empirical approaches, we demonstrate the accuracy and superiority of the skeleton-based method for measuring wall thickness while discussing its interpretation and limitations. Finally, we present a new freely available software tool, the VMI Calculator, to facilitate wall thickness measurements using our novel method. © 2016 by John Wiley & Sons, Inc.
Copyright © 2016 John Wiley & Sons, Inc.

Entities:  

Keywords:  morphometry; pulmonary hypertension; wall thickness

Mesh:

Year:  2016        PMID: 27723088      PMCID: PMC6431235          DOI: 10.1002/cpcy.10

Source DB:  PubMed          Journal:  Curr Protoc Cytom        ISSN: 1934-9297


  11 in total

Review 1.  Small artery remodeling and significance in the development of hypertension.

Authors:  Michael J Mulvany
Journal:  News Physiol Sci       Date:  2002-06

Review 2.  Pulmonary arterial hypertension.

Authors:  Harrison W Farber; Joseph Loscalzo
Journal:  N Engl J Med       Date:  2004-10-14       Impact factor: 91.245

Review 3.  Development and pathology of pulmonary hypertension.

Authors:  Rubin M Tuder; Steven H Abman; Thomas Braun; Frédérique Capron; Troy Stevens; Patricia A Thistlethwaite; Sheila G Haworth
Journal:  J Am Coll Cardiol       Date:  2009-06-30       Impact factor: 24.094

4.  An official research policy statement of the American Thoracic Society/European Respiratory Society: standards for quantitative assessment of lung structure.

Authors:  Connie C W Hsia; Dallas M Hyde; Matthias Ochs; Ewald R Weibel
Journal:  Am J Respir Crit Care Med       Date:  2010-02-15       Impact factor: 21.405

5.  Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension.

Authors:  L Taraseviciene-Stewart; Y Kasahara; L Alger; P Hirth; G Mc Mahon ; J Waltenberger; N F Voelkel; R M Tuder
Journal:  FASEB J       Date:  2001-02       Impact factor: 5.191

6.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

7.  NIH Image to ImageJ: 25 years of image analysis.

Authors:  Caroline A Schneider; Wayne S Rasband; Kevin W Eliceiri
Journal:  Nat Methods       Date:  2012-07       Impact factor: 28.547

8.  The Sugen 5416/hypoxia mouse model of pulmonary hypertension revisited: long-term follow-up.

Authors:  Sally H Vitali; Georg Hansmann; Chase Rose; Angeles Fernandez-Gonzalez; Annette Scheid; S Alex Mitsialis; Stella Kourembanas
Journal:  Pulm Circ       Date:  2014-12       Impact factor: 3.017

9.  A novel murine model of severe pulmonary arterial hypertension.

Authors:  Loredana Ciuclan; Olivier Bonneau; Martin Hussey; Nicholas Duggan; Alan M Holmes; Robert Good; Rowan Stringer; Peter Jones; Nicholas W Morrell; Gabor Jarai; Christoph Walker; John Westwick; Matthew Thomas
Journal:  Am J Respir Crit Care Med       Date:  2011-08-25       Impact factor: 21.405

Review 10.  Mechanisms of disease: pulmonary arterial hypertension.

Authors:  Ralph T Schermuly; Hossein A Ghofrani; Martin R Wilkins; Friedrich Grimminger
Journal:  Nat Rev Cardiol       Date:  2011-06-21       Impact factor: 32.419

View more
  2 in total

1.  Treatment With Treprostinil and Metformin Normalizes Hyperglycemia and Improves Cardiac Function in Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction.

Authors:  Longfei Wang; Gunner Halliday; Joshua R Huot; Taijyu Satoh; Jeffrey J Baust; Amanda Fisher; Todd Cook; Jian Hu; Theodore Avolio; Dmitry A Goncharov; Yang Bai; Rebecca R Vanderpool; Robert V Considine; Andrea Bonetto; Jiangning Tan; Timothy N Bachman; Andrea Sebastiani; Charles F McTiernan; Ana L Mora; Roberto F Machado; Elena A Goncharova; Mark T Gladwin; Yen-Chun Lai
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-04-09       Impact factor: 8.311

2.  Differential effects of integrin-linked kinase inhibitor Cpd22 on severe pulmonary hypertension in male and female rats.

Authors:  Yuanjun Shen; Dmitry A Goncharov; Theodore Avolio; Arnab Ray; Evelyn Okorie; Horace DeLisser; Ana L Mora; Rebecca Vanderpool; Tatiana V Kudryashova; Elena A Goncharova
Journal:  Pulm Circ       Date:  2020-02-12       Impact factor: 3.017

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.